Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / SLAM BioTherapeutics, Inc.

SLAM BioTherapeutics, Inc.

Stage unknownWestlake Village, CABiotechnology
Facts
Year of incorporation
2022sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
2 rounds
  1. Dec 19, 2025
    Form D equity offering · $1.0M (form d sold) · 1 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “SLAM BioTherapeutics, Inc. filed Form D: $1,000,000 sold of $4,000,000, Biotechnology”
  2. Feb 20, 2025
    Form D equity offering · $500,000 (form d sold) · 1 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “SLAM BioTherapeutics, Inc. filed Form D: $500,000 sold of $10,000,000, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
2 officers, 5 directors
Timeline
2
  1. Dec 29, 2025
    SLAM BioTherapeutics, Inc. filed Form D: $1,000,000 sold of $4,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Mar 3, 2025
    SLAM BioTherapeutics, Inc. filed Form D: $500,000 sold of $10,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
30 observations
Every observation on this company